Published in
Taylor and Francis Group, Leukemia & Lymphoma, 8(63), p. 1942-1948, 2022
DOI: 10.1080/10428194.2022.2057488
Links
Tools
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Journal article published in 2022 by
Theodoros Karantanos,
Hua-Ling Tsai,
Lukasz P. Gondek,
Amy E. DeZern,
Gabriel Ghiaur,
W. Brian Dalton 
,
Ivana Gojo,
Gabrielle T. Prince,
Jonathan Webster ,
Alexander Ambinder,
B. Douglas Smith,
Mark J. Levis,
Ravi Varadhan,
Richard J. Jones,
Tania Jain
,
Ivana Gojo,
Gabrielle T. Prince,
Jonathan Webster ,
Alexander Ambinder,
B. Douglas Smith,
Mark J. Levis,
Ravi Varadhan,
Richard J. Jones,
Tania Jain
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 